- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceutical industry: the cost of introducing a new product 1979-2012
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pharmaceutical industry: the cost of introducing a new product 1979-2012
Estimated costs for the introduction of a new chemical or biological pharmaceutical product from 1979 to 2012 (in million U.S. dollars)
This statistic represents the estimated costs of introducing a new chemical or biological product in the pharmaceutical market from 1979 to 2012. In 1979, the costs to bring a new chemical or biological pharmaceutical product to market were at some 200 million U.S. dollars. Some 30 years later, these costs stood at some estimated 1.5 billion U.S. dollars.
Estimated costs for the introduction of a new chemical or biological pharmaceutical product from 1979 to 2012 (in million U.S. dollars)
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- June 2015
- Region
- Worldwide
- Survey time period
- 1979 to 2012
- Supplementary notes
-
EFPIA stands for European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several efpia reports.
* In 2011 U.S. dollars. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- June 2015
More information
- Region
- Worldwide
- Survey time period
- 1979 to 2012
- Supplementary notes
-
EFPIA stands for European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several efpia reports.
* In 2011 U.S. dollars. - Open this statistic in...
Other statistics on the topic
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate solution including all features.
Prices do not include sales tax.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
- Overview
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Annual compensation in U.S. biopharmaceutical industry vs. national average 2015
- Most commonly used non-subsidized prescription drugs Australia 2015
- Biopharmaceutical industry employee number by subsector U.S. 2015
- Most important subsidized drugs prescribed by optometrists 2015
- Most prescribed prescription drugs Australia 2018
- Most commonly used prescription drugs Australia 2018
- Sales growth of pharmaceutical therapeutic areas
- Most prescribed subsidized prescription drugs by optometrists Australia 2015
- Advertising expenditure for pharmaceutical products in Germany 2000-2017
- Total number of subsidized prescriptions Australia 2013-2015
- Sales of the top pharmaceutical therapeutic areas
- Most important subsidized drugs prescribed by nurses Australia by total cost 2015
- U.S. adults impression of the U.S. pharma companies availability of their products
- Most commonly used subsidized prescription drugs Australia 2015
- Employees in U.S. biopharmaceutical industry by occupational share 2015
- Europe: sales of top selling pharmaceutical products 2015
- Value medical device exports from Japan 2011-2016
- Value medical device exports from Japan 2016, by region
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.